دورية أكاديمية
أعرض في EDS

Current and emerging treatment options for myopic choroidal neovascularization

التفاصيل البيبلوغرافية
العنوان: Current and emerging treatment options for myopic choroidal neovascularization
المؤلفون: El Matri L, Chebil A, Kort F
المصدر: Clinical Ophthalmology, Vol 2015, Iss default, Pp 733-744 (2015)
بيانات النشر: Dove Medical Press, 2015.
سنة النشر: 2015
المجموعة: LCC:Ophthalmology
مصطلحات موضوعية: Ophthalmology, RE1-994
الوصف: Leila El Matri, Ahmed Chebil, Fedra Kort Department B of Ophthalmology, Hedi Rais Institute of Ophthalmology, Faculty of Medicine of Tunis, University of El Manar, Tunis, Tunisia Abstract: Choroidal neovascularization (CNV) is the main cause of visual impairment in highly myopic patients younger than 50 years of age. There are different treatments for myopic CNV (mCNV), with 5- to 10-year outcomes currently. Chorioretinal atrophy is still the most important determinant factor for visual outcome. The purpose of this study is to provide an overview of the current treatments for mCNV, including laser, surgical management, verteporfin photodynamic therapy, and mainly anti-vascular endothelial growth factor therapy. Emerging treatment options are also discussed. Keywords: myopia, choroidal neovascularization, current treatment, emerging treatment
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1177-5483
Relation: http://www.dovepress.com/current-and-emerging-treatment-options-for-myopic-choroidal-neovascula-peer-reviewed-article-OPTH; https://doaj.org/toc/1177-5483
URL الوصول: https://doaj.org/article/005ac5f1dc0446f0aa68ddca5c818d84
رقم الأكسشن: edsdoj.005ac5f1dc0446f0aa68ddca5c818d84
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:11775483